Literature DB >> 6461305

Down's syndrome as a model disease.

C H Scoggin, D Patterson.   

Abstract

Aneuploid chromosomal disorders may offer insight into the pathogenesis of certain common diseases. The birth defects and mental retardation that characterize Down's syndrome are well recognized. In addition, the altered chromosomal content that occurs in the syndrome apparently affects the prevalence of a variety of disorders, such as malignancy, endocrine dysfunction, infection, atherosclerosis, and premature aging. Because the single distinguishing factor in Down's syndrome is the presence of an excess of a part of chromosome 21, the genetic information contained in this chromosomal segment seems to be responsible for the disease manifestations. Techniques of somatic cell genetics and molecular biology allow mapping of human genes and study of their expression. With such methods it should be possible to understand Down's syndrome and other aneuploid disorders and to apply these considerations to other areas of medicine.

Entities:  

Mesh:

Year:  1982        PMID: 6461305

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Malignancies in Down syndrome.

Authors:  P Kusumakumary; T S Vats; R Ankathil; H R Gattamaneni; M K Nair
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

Review 2.  The new biomedical technology.

Authors:  C H Scoggin
Journal:  West J Med       Date:  1985-12

3.  Two-dimensional gel analysis of proteins from human trisomy 21 fetal liver tissue after DEAE-Sepharose chromatography.

Authors:  G H Reichert
Journal:  Hum Genet       Date:  1986-07       Impact factor: 4.132

4.  A mathematically designed STS primer without any mismatches for direct sequencing of cosmid DNA clones.

Authors:  X Tang; Y Wang; Y Nakata; H O Li; A Fujita; H Gao; A Sarai; K Yokoyama
Journal:  Jpn J Hum Genet       Date:  1993-12

5.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

6.  Human Cu/Zn superoxide dismutase gene family: molecular structure and characterization of four Cu/Zn superoxide dismutase-related pseudogenes.

Authors:  E Danciger; N Dafni; Y Bernstein; Z Laver-Rudich; A Neer; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation.

Authors:  O Elroy-Stein; Y Bernstein; Y Groner
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

8.  Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity.

Authors:  M Schickler; H Knobler; K B Avraham; O Elroy-Stein; Y Groner
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.